Community-driven strategies for the use of antiretrovirals as prevention: United States Workshop Report

Launched in 2011, the multi-national Mapping Pathways project provides a community-led, research-driven, multi-layered synthesis about the use of antiretroviral-based prevention strategies. Project partners included RAND, AIDS Foundation of Chicago, AIDS United, Desmond Tutu HIV Foundation, Naz India, and Bairds CMC.

In the latter half of 2013, a subset of the Mapping Pathways team from RAND Europe and AIDS Foundation of Chicago conducted a series of three “knowledge exchange” scenario development workshops with a focus on the United States, held in San Francisco, California; Atlanta, Georgia; and Washington, DC. The aim of the workshops was to further share the findings of the report and to continue enhancing the community-driven, locally informed approach to the wider evidence base for ARV-based prevention. This report summarizes the outputs of those three workshops.

Mapping Pathways: Developing evidence-based, people-centred strategies for the use of antiretrovirals as prevention

Mapping Pathways is a multinational project to develop and nurture a research-driven, community-led global understanding of the emerging evidence base around the adoption of antiretroviral (ARV)-based prevention strategies to end the HIV/AIDS epidemic. The project is based on the premise that the current array of prevention options is not sufficient; new pathways to prevention, based on enhanced assessment and analysis of likely impact, are needed to address new infections adequately.

GPP Trial Site Binder

The GPP Trial Site Binder is a companion tool to the Good Participatory Practice guidelines that research teams can use to help develop, organize and document the stakeholder engagement activity at the site. The binder is is divided into sixteen sections aligned with the guidelines. Each section contains key steps to help research staff follow the practices, templates for documenting and planning activities, and a place to file draft documents.  

Good Participatory Practice: Guidelines for TB Drug Trials

The Good Participatory Practice (GPP) guidelines for TB Drug Trials is the product of a collaboration between AVAC and the Stakeholder and Community Engagement Workgroup of the Critical Path to TB Drug Regimens. The guidelines offer trial funders, sponsors, and implementers systematic guidance on how to engage stakeholders throughout the research lifecycle. This first edition, published in 2012, contains five sections that provide context, foundational principles, and key practices for conducting TB drug trials.  

GPP Overview PowerPoint

The GPP Overview PowerPoint contains 35 slides that users can draw from when introducing the Good Participatory Practice guidelines.  The PowerPoint contains slides on the history and content of the guidelines, who the intended user is,  the role and importance of GPP in the field and strategies for effective use. The slide deck is broken into sections allowing slides can be rearranged or deleted to make a complete presentation.  

African Women’s Civil Society Consultation on HIV Risk and Hormonal Contraceptives

More than 40 women representing HIV prevention advocates, reproductive health service providers, and women living with HIV from Kenya, South Africa, Rwanda, Uganda and Zimbabwe met to review and discuss the existing data on hormonal contraceptive use and HIV risk.

The Change We Need to End AIDS in Uganda: A civil society analysis of the state of Uganda’s AIDS response

This document, developed by a coalition of civil society groups co-led by AVAC Advocacy Fellows Alice Kayong-Mutebi, Richard Hasunira and Sylvia Nakasi, identifies failures in the Ugandan AIDS response and a 10-point plan to end the country’s epidemic.

Letter to Ambassador Goosby on PEPFAR and the national response to HIV in Uganda in 2012-13

This letter, written by a coalition of civil society groups co-led by AVAC Advocacy Fellows Alice Kayong-Mutebi, Richard Hasunira and Sylvia Nakasi, summarizes concerns and demands related to the US PEPFAR program’s 2012 Country Operating Plan. A country operating plan dictates the scope, funding levels and targets of PEPFAR programming on an annual basis.

Ugandan Service Provider Perspectives on the WHO Recommendation on Hormonal Contraceptives and HIV Risk

This abstract poster, developed by 2012 AVAC Advocacy Fellow Lydia Mulwanyi-Mukombe and her Host, Lillian Mworeko, describes key findings from consultations with Uganda service providers. It reports how providers were planning to use the new WHO guidance and makes recommendations for how to protect and inform women in light of the potential HIV risk associated with hormonal contraceptive use.

Community Involvement in HIV Prevention Research: Experiences and perceptions of communities participating in the MDP 301 microbicide trial in Masaka, Uganda

This case study by 2010 AVAC Advocacy Fellow Richard Hasunira assesses the community engagement efforts of the Masaka trial site through interviews with participants, trial staff, and other stakeholders. It highlights success that other trials should replicate and lessons learned from shortcomings.